VSMD Stock Overview
Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Vasamed, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| VSMD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 1.8% | 3.3% |
| 1Y | n/a | 0.6% | 25.8% |
Return vs Industry: Insufficient data to determine how VSMD performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how VSMD performed against the US Market.
Price Volatility
| VSMD volatility | |
|---|---|
| VSMD Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: VSMD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine VSMD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | Mike Schreiber | www.vasamed.com |
Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. It offers SensiLase PAD-IQ, which supports skin perfusion pressure, pulse volume recording, and ankle brachial index calculation for Doppler-obtained pressures; and Wound Imaging & SmartDraw wound measurement systems. The company also provides PAD-IQ Studycast that provides rapid transmission of diagnostic tests to vascular specialist for interpretation of results and medically indicated therapeutic intervention; and custom carrying case to secure and protect the PAD-IQ system.
Vasamed, Inc. Fundamentals Summary
| VSMD fundamental statistics | |
|---|---|
| Market cap | US$8.00 |
| Earnings (TTM) | -US$1.93m |
| Revenue (TTM) | US$3.43m |
0.0x
P/S Ratio0.0x
P/E RatioIs VSMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VSMD income statement (TTM) | |
|---|---|
| Revenue | US$3.43m |
| Cost of Revenue | US$1.45m |
| Gross Profit | US$1.98m |
| Other Expenses | US$3.91m |
| Earnings | -US$1.93m |
Last Reported Earnings
Jun 30, 2009
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did VSMD perform over the long term?
See historical performance and comparison